Trial Profile
A Methodology Study To Evaluate Cerebrospinal Fluid Acetylcholine Following A Single Dose Administration Of Donepezil In Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Donepezil (Primary)
- Indications Alzheimer's disease
- Focus Pharmacodynamics
- Sponsors Pfizer
- 03 Mar 2010 Actual patient number (12) added as reported by ClinicalTrials.gov.
- 03 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Feb 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.